In 2026,Global Frozen Tissues Samples Size Is Estimated To Be USD 81 Million

Frozen tissues, on the other hand, work very well for molecular genetic analysis – especially if the biopsy materials are dipped in liquid nitrogen in a method called “flash freezing,” and then stored in an ultra-cold freezer at less than -80 degrees Celsius.    Frozen tissue array samples are also very useful for IHC analysis, since proteins are preserved in a native state.  These “native” non-denatured proteins can also be isolated in a still active form, for biochemical analysis.  
The global Frozen Tissues Samples size is estimated to be USD 81 million in 2026 from USD 45 million in 2020. The global Frozen Tissues Samples market size is expected to grow at a CAGR of 15.7% for the next five years.

Market competition is intense. Precision for Medicine, ProteoGenex, Bay BioSciences, Zen-Bio, OriGene Technologies, AMS Biotechnology (Europe), etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.